Cleared Traditional

K201042 - PROBEAT-CR

K201042 is the FDA 510(k) clearance for PROBEAT-CR by Hitachi , Ltd.. It is a Class 2 Radiology device (product code LHN) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K201042 · Hitachi , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
84d
Days
Class 2
Risk

K201042 is an FDA 510(k) clearance for the PROBEAT-CR. Classified as System, Radiation Therapy, Charged-particle, Medical (product code LHN), Class II - Special Controls.

Submitted by Hitachi , Ltd. (Kashiwa-Shi, JP). The FDA issued a Cleared decision on July 13, 2020 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hitachi , Ltd. devices

Submission Details

510(k) Number K201042 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 2020
Decision Date July 13, 2020
Days to Decision 84 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 107d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LHN System, Radiation Therapy, Charged-particle, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Hogan & Lovells US LLP
Jonathan Kahan

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LHN System, Radiation Therapy, Charged-particle, Medical

All 30
Devices cleared under the same product code (LHN) and FDA review panel - the closest regulatory comparables to K201042.
Small Field Applicator
K220883 · Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha · Dec 2022
ProBeam 360° Proton Therapy System
K221791 · Varian Medical Systems, Inc. · Dec 2022
myQA iON
K201798 · Iba Dosimetry GmbH · Jul 2020
Orfit Aerial Couchtop
K200282 · Orfit Industries NV · Apr 2020
Blue Phantom PT
K191821 · Iba Dosimetry GmbH · Jan 2020
Radiance 330 Proton Beam Therapy System
K191521 · Protom International Holding Corporation · Sep 2019